HUYA Bioscience International LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HUYA Bioscience International LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2797
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HUYA Bioscience International LLC (HUYA) is a biopharmaceutical company that develops early and late-stage drug candidates. The company’s pipeline products include HBI-8000, HBI-3000, and HBI-3802. Its HBI-8000 is a novel oral inhibitor of histone deacetylases; HBI-3000 is a channel blocker for the treatment of arrhythmia and HBI-3802 is a small molecule with preclinical activity to improve heart function. HUYA also identifies and licenses pre-clinical and clinical stage compounds. The company develops drugs in the areas of oncology and cardiovascular. It has operations in the US, Ireland, China, Japan and South Korea. HUYA is headquartered in Shanghai, China.

HUYA Bioscience International LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
HUYA Bioscience International Enters into Agreement with CAS Innovation 10
Huya Bioscience to form Joint Venture with Tianjin Institute of Pharma 11
HUYA Bioscience Enters Into Co-Development Agreement With TJRCBMS 12
Licensing Agreements 13
HUYA Bioscience Enters into Licensing Agreement with Fudan University 13
HUYA Bioscience International Enters into Licensing Agreement with Eisai 14
HUYA Bioscience International LLC – Key Competitors 15
HUYA Bioscience International LLC – Key Employees 16
HUYA Bioscience International LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Key Facts 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HUYA Bioscience International LLC, Deals By Therapy Area, 2012 to YTD 2018 8
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HUYA Bioscience International Enters into Agreement with CAS Innovation 10
Huya Bioscience to form Joint Venture with Tianjin Institute of Pharma 11
HUYA Bioscience Enters Into Co-Development Agreement With TJRCBMS 12
HUYA Bioscience Enters into Licensing Agreement with Fudan University 13
HUYA Bioscience International Enters into Licensing Agreement with Eisai 14
HUYA Bioscience International LLC, Key Competitors 15
HUYA Bioscience International LLC, Key Employees 16
HUYA Bioscience International LLC, Other Locations 17

List of Figures
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HUYA Bioscience International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HUYA Bioscience International LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kobe Steel, Ltd.:戦略・SWOT・企業財務分析
    Kobe Steel, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kobe Steel, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cowen Inc:企業の戦略・SWOT・財務情報
    Cowen Inc - Strategy, SWOT and Corporate Finance Report Summary Cowen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Flint Group SA:企業の戦略的SWOT分析
    Flint Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Avantis Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Avantis Medical Systems Inc (AMS) is a medical device company that provides visualization technology solutions. The company provides products such as single camera colonoscopy devices and third eye panoramic devices. Its third eye panoramic devices provide two side-viewing cameras supplement …
  • Societe Generale S.A.:戦略・SWOT・企業財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Becle S.A.B. de C.V. (CUERVO):企業の財務・戦略的SWOT分析
    Becle S.A.B. de C.V. (CUERVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • DTE Energy Co (DTE)-エネルギー分野:企業M&A・提携分析
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • Alta Mesa Resources Inc:企業の戦略的SWOT分析
    Alta Mesa Resources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Helix BioPharma Corp (HBP)-製薬・医療分野:企業M&A・提携分析
    Summary Helix BioPharma Corp (Helix) is a biopharmaceutical company with a focus in the field of cancer therapy. The company develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anti-cance …
  • VWR Corp (VWR)-医療機器分野:企業M&A・提携分析
    Summary VWR Corp (VWR) is a medical equipment company that distributes laboratory products, and provides services and solutions. The company offers product such chemicals, reagents, consumables, durable products, scientific equipment and instruments. It offers products in the areas of research and d …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • B&G Foods, Inc.:企業の戦略・SWOT・財務情報
    B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Genentech, Inc.:企業のM&A・事業提携・投資動向
    Genentech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genentech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • ALFA, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • U.S. Preventive Medicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Preventive Medicine Inc (USPM) is a healthcare service center that provides wellness and care management services. The center offers preventive plan, a web-based or online health management platform for the clinical science of preventive medicine. Its preventive plan library provides in …
  • Electricity Generating Public Co Ltd (EGCO)-エネルギー分野:企業M&A・提携分析
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • Jardine Matheson Holdings Ltd
    Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Titan Logix Corp (TLA):企業の財務・戦略的SWOT分析
    Summary Titan Logix Corp (Titan) is a technology company that offers research and development, manufacturing and marketing of advanced technology fluid management solutions. The company's products include stationary guided wave radar gauges for level measurement and overfill prevention, for use in t …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務情報
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bank Hapoalim Bm
    Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆